We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

37 hedge funds and large institutions have $20.2M invested in Gyre Therapeutics in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,781% more call options, than puts

Call options by funds: $1.1M | Put options by funds: $16K

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

35% more capital invested

Capital invested by funds: $15M → $20.2M (+$5.19M)

23% more funds holding

Funds holding: 30 → 37 (+7)

0.25% more ownership

Funds ownership: 1.47% → 1.72% (+0.25%)

Holders
37
Holders Change
+7
Holders Change %
+23.33%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
6
Closed
4
Calls
$1.1M
Puts
$16K
Net Calls
+$1.08M
Net Calls Change
+$59K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.4M
2
Charles Schwab
Charles Schwab
California
+$1.17M
3
Northern Trust
Northern Trust
Illinois
+$800K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$565K
5
AACP
Advantage Alpha Capital Partners
California
+$343K

Top Sellers

1
WG
Winton Group
United Kingdom
-$220K
2
Renaissance Technologies
Renaissance Technologies
New York
-$166K
3
Marshall Wace
Marshall Wace
United Kingdom
-$128K
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$96.7K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$74.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
26
Ameritas Investment Partners
Nebraska
$8.56K – – –
Legal & General Group
27
Legal & General Group
United Kingdom
$7.62K – – –
AWM
28
Activest Wealth Management
Florida
$6.68K – – –
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$6.33K – – –
Osaic Holdings
30
Osaic Holdings
Arizona
$5.53K -$2.58K -200 -31%
AB
31
Amalgamated Bank
New York
$3K – – –
Nisa Investment Advisors
32
Nisa Investment Advisors
Missouri
$1.05K +$1.08K +84 New
SCM
33
Sterling Capital Management
North Carolina
$263 +$271 +21 New
CPA
34
Capital Performance Advisors
California
$75 +$77 +6 New
DB
35
Danske Bank
Denmark
$13 +$13 +1 New
WG
36
Winton Group
United Kingdom
– -$220K -18,467 Closed
Renaissance Technologies
37
Renaissance Technologies
New York
– -$166K -13,900 Closed
Marshall Wace
38
Marshall Wace
United Kingdom
– -$128K -10,720 Closed
C
39
Covestor
United Kingdom
– +$77 +6 New
Carson Wealth (CWM LLC)
40
Carson Wealth (CWM LLC)
Nebraska
– +$387 +30 New
1
2

GYRE Hedge Fund Activity: Q3 2024 in Review

37 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q3 2024, worth a combined $20.2M — up 35% from $15M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GYRE positions and 4 closed out — a net gain of 7 holders — while 15 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.4M. The largest seller was Winton Group, exiting entirely with an estimated $220K sold.

  • 37 institutional investors held Gyre Therapeutics (GYRE) as of Q3 2024, up from 30 in Q2 2024.
  • Funds reported $20.2M of Gyre Therapeutics stock for Q3 2024, up 35% quarter-over-quarter.
  • 11 funds opened new Gyre Therapeutics positions in Q3 2024 and 4 closed out, a net change of +7 holders.
  • The largest Gyre Therapeutics buyer in Q3 2024 was Vanguard Group, an estimated $1.4M added.
  • The largest Gyre Therapeutics seller in Q3 2024 was Winton Group, an estimated $220K sold.

Based on aggregated 13F filings for Q3 2024.